Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medistep HealthcareNSE:MEDISTEP 19 3-Year ROIIC % is 22.54 as of Mar. 2025, which is at its 10-year median of 22.54. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, Medistep Healthcare ranks better than 89.29% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Medistep Healthcare's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was 22.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medistep Healthcare's 3-Year ROIIC % or its related term are showing as below:
NSE:MEDISTEP's 3-Year ROIIC % is ranked better than 89.29% of 112
companies
in the Medical Distribution industry
Industry Median: 2.295
vs NSE:MEDISTEP: 22.54
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medistep Healthcare 3-Year ROIIC % Related Terms
Medistep Healthcare 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDISTEP vs MCK, COR, CAH: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, Medistep Healthcare's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medistep Healthcare (NSE:MEDISTEP) has a 3-Year ROIIC % of 22.54 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medistep Healthcare and its competitors. This is near median its historical median of 22.54. Over the past decade, Medistep Healthcare's 3-Year ROIIC % has ranged from 22.54 to 22.54. According to the industry distribution chart, Medistep Healthcare ranks #12 out of 112 companies in the Medical Distribution industry, placing it in the top 10.7%.
Is Medistep Healthcare's 3-Year ROIIC % too high?
Medistep Healthcare's current 3-Year ROIIC % of 22.54 is near median its 10-year median of 22.54. Over the past 10 years, this metric has ranged from a low of 22.54 to a high of 22.54. The Medical Distribution industry median 3-Year ROIIC % is 2.30. Medistep Healthcare's value of 22.54 is 882.1% above this industry median. Based on the distribution chart, Medistep Healthcare ranks #12 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's 3-Year ROIIC % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #12 out of 112 companies for 3-Year ROIIC %. This places Medistep Healthcare in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 2.30. Medistep Healthcare's value of 22.54 is 882.1% above this benchmark. Historically, Medistep Healthcare's own 3-Year ROIIC % has ranged from 22.54 to 22.54 over the past decade. While the company's 10-year median is 22.54 vs. the industry median of 2.30, Medistep Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.30, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current 3-Year ROIIC % of 22.54 is 882.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current 3-Year ROIIC % is 22.54, which is near median its own 10-year median of 22.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current 3-Year ROIIC % of 22.54. The current 3-Year ROIIC % is 22.54, which is near median its 10-year median of 22.54 and 882.1% above the Medical Distribution industry median of 2.30. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current 3-Year ROIIC % is 22.54 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 
